Taken together, these findings highlight NLRP3 inflammasome inhibition as a convergent and critical pathway through which AdipoRon exerts its neuroprotective and antidepressant effects, reinforcing the inflammasome’s role as a promising therapeutic target with AdipoRon in mood disorders. This evidence concerns the gene NLRP3 and mood disorder.